Advisor Group Holdings, Inc. Sonoma Pharmaceuticals, Inc. Transaction History

Advisor Group Holdings, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$0.14 - $0.26 $28 - $52	200 New	200 $0
Q3 2023 Nov 13, 2023	SELL	$0.76 - $1.16 $126 - $192	-166 Reduced 76.85%	50 $0
Q1 2023 May 12, 2023	BUY	$0.94 - $2.02 $47 - $101	50 Added 30.12%	216 $0
Q1 2022 May 04, 2022	SELL	$2.65 - $4.84 $2 - $4	-1 Reduced 0.6%	166 $1,000
Q3 2021 Nov 05, 2021	BUY	$5.23 - $8.89 $5 - $8	1 Added 0.6%	167 $1,000
Q2 2021 Aug 02, 2021	SELL	$7.12 - $9.15 $946 - $1,216	-133 Reduced 44.48%	166 $1,000
Q1 2021 May 13, 2021	BUY	$6.81 - $9.64 $905 - $1,282	133 Added 80.12%	299 $2,000
Q1 2020 May 18, 2020	BUY	$3.71 - $6.05 $615 - $1,004	166 New	166 $1,000

2.27K

Ticker SNOA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,100,940
Market Cap $8.31M
Description
Sonoma Pharmaceuticals, Inc., develops and produces stabilized hypochlorous acid (HOCl) products for wound care, animal health care, eye care, oral care, and dermatological conditions in the United States, Latin America, Europe, and internationally. The company offers Epicyn, an antimicrobial facial cleanser; Levicyn, an HOCl based prescription ...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.